LSB Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: LakeShore Biopharma Co., Ltd.

LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting

a month ago - By: Benzinga - Mentions: GRI IVA COCP ADXN ...

12 Health Care Stocks Moving In Friday's Pre-Market Session

a month ago - By: LakeShore Biopharma Co., Ltd.

LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq

2 months ago - By: LakeShore Biopharma Co., Ltd.

LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

2 months ago - By: Stocktwits

LakeShore Biopharma Receives Revised Proposal To Acquire Company

2 months ago - By: Benzinga - Mentions: CVM TLX COO GLMD ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session

2 months ago - By: LakeShore Biopharma Co., Ltd.

LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee

2 months ago - By: Stocktwits

LakeShore Biopharma Just Got An Acquisition Proposal From Oceanpine Capital: More Details Inside

3 months ago - By: LakeShore Biopharma Co., Ltd.

LakeShore Biopharma Announces Fiscal Year 2025 Financial Results

4 months ago - By: LakeShore Biopharma Co., Ltd.

LakeShore Biopharma Announces US$15 Million Private Placement Financing

a year ago - By: LakeShore Biopharma Co., Ltd

Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024

a year ago - By: LakeShore Biopharma Co., Ltd.

LakeShore Biopharma Announces Leadership Transitions

6 months ago - By: LakeShore Biopharma Co., Ltd.

LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA™ Rabies Vaccine (Vero Cell)

10 months ago - By: LakeShore Biopharma

LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance

11 months ago - By: LakeShore Biopharma Co., Ltd

LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China

11 months ago - By: LakeShore Biopharma Co., Ltd

LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China

a year ago - By: LakeShore Biopharma Co., Ltd - Mentions: YS

LakeShore Biopharma Initiates Biologics License Application of PIKA Rabies Vaccine to the Drug Regulatory Authority of Pakistan

a year ago - By: LakeShore Biopharma Co., Ltd

LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

a year ago - By: LakeShore Biopharma Co., Ltd.

LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine

a year ago - By: LakeShore Biopharma Co., Ltd.

LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance

a year ago - By: LakeShore Biopharma Co., Ltd.

LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation

a year ago - By: LakeShore Biopharma Co., Ltd

LakeShore Biopharma Announces Financial Results for Fiscal Year 2024

a year ago - By: LakeShore Biopharma Co., Ltd

LAKESHORE BIOPHARMA CO LTD (LSB) Stock News

LSB Latest News, Press Relases and Analysis

LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting

12 Health Care Stocks Moving In Friday's Pre-Market Session

LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq

LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

LakeShore Biopharma Receives Revised Proposal To Acquire Company

12 Health Care Stocks Moving In Thursday's Pre-Market Session

LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee

LakeShore Biopharma Just Got An Acquisition Proposal From Oceanpine Capital: More Details Inside

LakeShore Biopharma Announces Fiscal Year 2025 Financial Results

LakeShore Biopharma Announces US$15 Million Private Placement Financing

Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024

LakeShore Biopharma Announces Leadership Transitions

LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA™ Rabies Vaccine (Vero Cell)

LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance

LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China

LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China

LakeShore Biopharma Initiates Biologics License Application of PIKA Rabies Vaccine to the Drug Regulatory Authority of Pakistan

LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine

LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance

LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation

LakeShore Biopharma Announces Financial Results for Fiscal Year 2024

LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition